G-MAB

Welcome to the Brand page for “G-MAB”, which is offered here for Therapeutic pharmaceutical for the treatment of cancer, neurodegerative diseases inflammatory diseases, and other conditions which can be treated, relieved or prevented by antibodies that bind to activate or block a target antigen;active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, neurodegerative diseases inflammatory diseases, and other conditions which can be treated, relieved or prevented by antibodies that bind to activate or block a target antigen;.

Its status is currently believed to be active. Its class is unavailable. “G-MAB” is believed to be currently owned by “Sorrento Therapeutics Inc.”